Abstract
We wanted to determine whether there is any advantage of using a mitral tissue valve, when aortic and mitral valves are simultaneously replaced. We placed a tissue valve in the mitral position and a mechanical valve in the aortic position in 22 cases (combined group). In 31 other double valve replacements, mechanical prostheses were chosen for both positions (mechanical group). The mean follow-up time for the combined group was 8.9 years, and that for the mechanical group was 7.2 years. The 10-year survival rate and freedom from thromboembolism at 10 years were not different in the two groups. Treatment-related hemorrhage was seen in 3 patients of the combined group alone. Five patients among the combined group underwent reoperation because of bioprosthetic dysfunction, and the rate of freedom from reoperation at 10 years was 75 ±12%. The rate of freedom from all complications at 10 years was 43±11% for the combined group and 70±8% for the mechanical group. We find no advantage in mixing aortic mechanical and mitral tissue valves when performing double valve replacement.
Similar content being viewed by others
References
Misawa Y, Hasegawa H, Kato K. Clinical experience with the Omnicarbon prosthetic heart valve. J Thorac Cardiovasc Surg 1993;105:168–172
Misawa Y, Konishi H, Fuse K, Hasegawa T, Kato M, Hasegawa N, Kawahito K. Mid term clinical results with the CarboMedics Prosthetic heart valve. Jpn J Thorac Cardiovasc Surg 1997; 25(suppl):113
Admunds LH, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guideline for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1996;62:932–935
Neville PH, Aupart MR, Diemont FF, Sirinelli AL, Lemoine EM, Marchand MA. Carpentier-Edwards pericardial bioprosthesis in aortic or mitral position: a 12-year experience. Ann Thorac Surg 1998;66:S143-S147
David TE, Armstrong S, Sun Z. The Hancok II bioprosthesis at 12 years. Ann Thorac Surg 1998;66:S95-S98
Glower DD, Landolfo KP, Cheruvu S, Cen YY, Harrison JK, Bashore TM, Smith PK, Jones RH, Wolfe WG, Lowe JE. Determinants of 15-year outcome with 1119 standard Carpentier-Edwards porcine valves. Ann Thorac Surg 1998;66:S44-S48
Jamieson WR, Burr LH, Miyagishima RT, Germann E, Anderson WN. Actuarial versus actual freedom from structural valve deterioration with the Carpentier-Edwards porcine bioprostheses. Can J Cardiol 1999;15:973–978
Misawa Y, Hasegawa T, Kato M. Clinical experience of tricuspid valve replacement with bioprosthetic valve. Jpn J Cardiovasc Surg 1992;21:229–232
Kobayashi Y, Eishi K, Nagata S, Sasako Y, Kobayashi J, Kosakai Y, Miyatake K. Choice of replacement valve in the elderly. J Heart Valve Dis 1997;6:404–409
Aupart MR, Neville PH, Hammami S, Sirinelli AL, Meurisse YA, Marchand MA. Carpentier-Edwards pericardial valves in the mitral position: ten-year follow-up. J Thorac Cardiovasc Surg 1997;113:492–498
Khan SS, Chaux A, Blanche C, Kass RM, Cheng W, Fontana GP, Trento A. A 20-year experience with the Hancock poreine xenograft in the elderly. Ann Thorac Surg 1998;66:S35-S39
Jamieson WR, Burr LH, Munro AI, Miyagishima RT. Carpentier-Edwards standard porcine bioprosthesis: a 21-year experience. Ann Thorac Surg 1998:66:S40-S43.
Bernal JM, Rabasa JM, Lopez R, Nistal JF, Muniz R, Revuelta JM. Durability of the Carpentier-Edwards porcine bioprosthesis: role of age and valve position. Ann Thorac Surg 1995;60:S248-S252
Yasuda K, Ayabe H, Ide H, Uchida Y. Thoracic and cardiovascular surgery in Japan during 1998. Jpn J Thorac Cardiovasc Surg 2000;48:401–415
Nistal JF, Hurle A, Revuelta JM, Grandarillas M. Clinical experience with the CarboMedies valve: early results with a new bileaflet mechanical prosthesis. J Thorac Cardiovasc Surg 1996;112:59–68
Darlymple-Hay MJR, Pearce R, Dawkins S, Haw MP, Lamb RK, Livesey SA, Monro JL. A single-center experience with 1378 CarboMedics mechanical valve implants. Ann Thorac Surg 2000; 69:457–463
Terregrosa S, Gomez-Plana J, Valera FJ, Caffarena J, Maronas J, Garcia-Sanchez F, Peris J, Rfias R, Caffarena JM. Long-term clinical experience with the Ominicarbon prosthetic valve. Ann Thorac Surg 1999;68:881–886
Zellner JL, Kratz JM, Crumbley AJ III, Stroud MR, Bradley SM, Sade RM, Crawford FA Jr. Long-term experience with the St. Jude Medical valve prosthesis. Ann Thorac Surg 1999;68:1210–1218.
Iguro Y, Moriyama Y, Yamaoka A, Yamashita M, Shimokawa S, Toyohira H, Taira A. Clinical experience of 473 patients with the Omnicarbon prosthetic heart valve. J Hear Valve Dis 1999;8:674–679
Jamieson WRE, Fradet GJ, Miyagishima RT, Henderson C, Brownlee RT, Zhang J, Germann E. CarboMedics mechanical prosthesis: performance at eight years. J Heart Valve Dis 2000;9: 678–681
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Misawa, Y., Fuse, K., Saito, T. et al. Increased risk for double valve replacement with tissue and mechanical prostheses. J Artif Organs 4, 298–302 (2001). https://doi.org/10.1007/BF02480021
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02480021